Related Experiment Video
Updated: Oct 30, 2025
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Meningococcus, this famous unknown
Isabel Dos Santos Souza1,2,3, Jason Ziveri2,2,3, Haniaa Bouzinba-Segard2,2,3
1CNRS, UMR8104, Paris, France.
Abstract:
Neisseria meningitidis (meningococcus) is a Gram-negative bacterium responsible for two devastating forms of invasive diseases: purpura fulminans and meningitis. Since the first description of the epidemic nature of the illness at the dawn of the nineteenth century, the scientific knowledge of meningococcal infection has increased greatly. Major advances have been made in the management of the disease with the advent of antimicrobial therapy and the implementation of meningococcal vaccines. More recently, an extensive knowledge has been accumulated on meningococcal interaction with its human host, revealing key processes involved in disease progression and new promising therapeutic approaches.
Insights
Neisseria meningitidis causes meningitis and purpura fulminans. Advances in antimicrobial therapy, vaccines, and understanding host interactions offer new therapeutic strategies for meningococcal infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Immunology
Background:
- Neisseria meningitidis (meningococcus) is a Gram-negative bacterium.
- It causes severe invasive diseases like meningitis and purpura fulminans.
- Historical understanding of meningococcal disease has evolved significantly.
Purpose of the Study:
- To review the scientific knowledge of meningococcal infections.
- To highlight advances in disease management and understanding of host-pathogen interactions.
- To explore emerging therapeutic approaches for meningococcal diseases.
Main Methods:
- Literature review of historical and recent scientific findings.
- Analysis of advancements in antimicrobial therapy and vaccine development.
- Examination of research on meningococcal-host interactions.
Main Results:
- Significant progress in managing meningococcal infections through antibiotics and vaccines.
- Accumulated knowledge on bacterial interaction with the human host.
- Identification of key processes in disease progression.
Conclusions:
- Antimicrobial therapy and vaccines have greatly improved meningococcal disease management.
- Understanding host-pathogen interactions reveals new therapeutic targets.
- Ongoing research promises novel strategies against invasive meningococcal disease.
Related Concept Videos
01:24Bacterial Phylum Tenericutes
01:28Fungal Phylum Microsporidia